Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKBA cream plus NB-UVB in pediatric non-segmental vitiligo
CTR20262064Phase 2Active
- Sponsor
- Bochuangyuan Biopharmaceutical
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 3-O-cyclohexanecarbonyl-11-keto-β-boswellic acid in Vitiligo, sponsored by Bochuangyuan Biopharmaceutical. Started May 2026; status: active.
02
Drugs
3-O-cyclohexanecarbonyl-11-keto-β-boswellic acid
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20262064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262064.